𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Rheumatoid arthritis and cardiovascular events

✍ Scribed by S. Stropuviene; S. Aidietiene; A. Cypiene; R. Rugiene; A. Laucevicius

Book ID
118419457
Publisher
Atlantis Press
Year
2011
Tongue
English
Weight
91 KB
Volume
5
Category
Article
ISSN
1872-9312

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Immunosuppressive medications and hospit
Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis
✍ Daniel H. Solomon; Jerry Avorn; Jeffrey N. Katz; Michael E. Weinblatt; Soko Seto πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 2 views

## Abstract ## Objective The risk of cardiovascular disease (CVD) is increased in patients with rheumatoid arthritis (RA), most likely because of increased systemic inflammation. Prior research suggests that immunosuppressive medications may reduce the risk of CVD among RA patients. This study was

Glucocorticoids and cardiovascular event
Glucocorticoids and cardiovascular events in rheumatoid arthritis: A population-based cohort study
✍ John M. Davis III; Hilal Maradit Kremers; Cynthia S. Crowson; Paulo J. Nicola; K πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 175 KB πŸ‘ 2 views

## Abstract ## Objective To determine the relationship between glucocorticoid exposure and cardiovascular (CV) events in patients with rheumatoid arthritis (RA). ## Methods A total of 603 adult residents of Rochester, Minnesota with incident RA between 1955 and 1995 were followed up through thei

HLA–DRB1 and persistent chronic inflamma
HLA–DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis
✍ Gonzalez-Gay, Miguel A. ;Gonzalez-Juanatey, Carlos ;Lopez-Diaz, Maria J. ;PiΓ±eir πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 88 KB πŸ‘ 2 views

## Abstract ## Objective Cardiovascular (CV) disease is the most common cause of mortality in patients with rheumatoid arthritis (RA). We assessed the contribution of epidemiologic features, clinical features, routine laboratory markers of inflammation, and HLA–DRB1 alleles to CV mortality in pati